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Sunday, February 3, 2013 17aother steep) in rat skinned cardiac myocytes, and (iii) troponin can be more
readily exchanged in permeabilized striated muscle cell preparations. To test
if PKA-mediated phosphorylation of cTnI is sufficient to mediate length
dependence of force we used skinned rat slow-twitch skeletal muscle fibers,
which exhibit shallow length-tension relationships that are unaltered by
PKA. A sarcomere length-tension relationship was measured during submaxi-
mal Ca2þ activation, then the fiber was incubated in a troponin (Tn) exchange
solution, which replaced ~80% of the endogenous slow-skeletal Tn with cTn.
After cTn incorporation the length-tension relationship remained shallow as
predicted since the purified cTnI lacks phosphate incorporation. Next, the fiber
was incubated in PKA, which caused the length-tension relationship to shift
from shallow to steep. In addition, exchange with cTn having cTnI serines
23/24 modified to aspartic acids to mimic phosphorylation steepened the
length-tension relationship. These results indicate that phosphorylation of
cTnI serines 23/24 is sufficient to control length dependence of force generation
in striated muscle.
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Background Recently, we observed reduced myofilament length-dependent
activation in cardiomyocytes from a patient harboring a homozygous mutation
(K280N) in the TNNT2 gene encoding cardiac troponin T (cTnT) compared to
non-failing donors. Protein kinase A (PKA)-mediated phosphorylation of car-
diac troponin I (cTnI) did not rescue impaired length-dependence. Moreover,
cTnI phosphorylation did not differ between TNNT2mut and donor myocardium.
In this study we present direct evidence that the K280N mutation in TNNT2
blunts length-dependent activation.
Methods Force measurements were performed in single permeabilized cardio-
myocytes isolated from the TNNT2mut heart at various [Ca
2þ] and sarcomere
lengths of 1.8 and 2.2 mm, with and without PKA-pretreatment. To investigate
if mutant cTnT underlies impaired length-dependent activation, the endoge-
nous mutant troponin complex was partially exchanged with recombinant
whole human wild-type troponin (Tnwt) complex. TNNT2mut sample was ex-
changed with 0.25, 0.5 and 1 mg/mL Tnwt complex, which in accordance
with previous studies from our group is predicted to yield ~40%, ~50% and
~70% of troponin exchange, respectively.
Results The length-dependent increase in myofilament Ca2þ-sensitivity
(DEC50) was not significantly different between TNNT2mut, TNNT2~40%,
TNNT2~50%, TNNT2~70%, (DEC50=0.3550.16, 0.2350.06, 0.0250.02 and
0.2250.06 mmol/L, respectively), but was significantly reduced compared to
donor (DEC50=0.7750.06 mmol/L). PKA-pretreatment did not restore
the reduced length-dependent activation of TNNT2mut and TNNT2~40%
(DEC50=0.2650.19 and 0.3250.15), but did recover the blunted length-
dependent activation of TNNT2~50% and TNNT2~70% (DEC50=0.7150.04 and
0.7950.14) to control values (DEC50=0.8250.09).
Conclusions Length-dependent activation of myofilaments is corrected to do-
nor values only when ~50% of mutant cTnT is replaced by wild-type troponin
and subsequent phosphorylation with PKA. Our data show that the TNNT2
mutation K280N underlies impaired length-dependent activation in a dose-
dependent manner.
93-Plat
2-deoxy-ATP Alters Myosin Structure to Enhance Cross-Bridge Cycling
and Improve Cardiac Function
Sarah G. Nowakowski1, Nancy Adamek2, Michael A. Geeves2,
Elizabeth Gay1, Stephen C. Kolwicz, Jr.1, Charles E. Murry1,
Valerie Daggett1, Michael Regnier1.
1University of Washington, Seattle, WA, USA, 2University of Kent,
Canterbury, United Kingdom.
We previously reported that increased cellular 2-deoxy-ATP (dATP) augments
contraction, enhancing the rate and magnitude of both contraction and relaxa-
tion in intact cardiomyocytes, force production in skinned cardiac muscle, and
fractional shortening of the whole heart. To better understand the mechanism
by which dATP enhances cardiac function, we used molecular dynamics
(MD) simulations to study the pre- and post-powerstroke states of myosin
(PDB ID: 1VOM and 1MMA) bound to either Mg2þ.(d)ADP.Pi (pre-power-
stroke) or Mg2þ.(d)ADP (post-powerstroke) for 50ns. In both states, dATP
binding to myosin alters the conformation of the nucleotide binding pocketand the actin binding surface. In the pre-powerstroke state, myosin made fewer
contacts with dADP than with ADP and this structural change translated
to increased exposure of polar residues on the actin-binding surface of
myosin. Since the initial acto-myosin interaction is primarily electrostatic,
the affinity of myosin for actin may thus be enhanced with dADP.Pi. In
post-powerstroke simulations, dADP binding reduced the exposure of actin
binding residues on myosin somewhat. This may translate into improved
ability for myosin detachment from actin at the end of the powerstroke in
the presence of dADP vs. ADP. Furthermore, stopped-flow spectroscopy
demonstrated that myosin has 40-80% weaker binding affinity for dADP
than ADP, which may also contribute to faster myosin detachment. Together,
these data demonstrate that dADP binding to myosin significantly alters the
conformation of myosin, which may translate to faster cross-bridge cycling
due to both enhanced myosin binding in the pre-powerstroke state and faster
myosin detachment from actin in the post-powerstroke state. Ongoing studies
examining the effect of enhanced cross-bridge cycling with elevated dATP in
infarcted hearts suggest that dATP may reduce the loss of systolic function.
Supported by HL111197 (MR), WT085309 (MAG), GM50789 (VD) and
T32EB001650 (SGN).
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Proper contraction and relaxation of the heart depends on highly orchestrated
and rapid release and reuptake of Ca2þ from the sarcoplasmic reticulum
(SR). Normal SR Ca2þ reuptake in the rodent heart is accomplished predomi-
nately by the cardiac Ca-ATPase, SERCA2a, which in the failing heart exhibits
diminished activity and expression. We have utilized a mouse model of
inducible cardiac Ca2þ dysregulation, the Serca2fl/fl mouse, to investigate the
relationship between diminished SR Ca2þ flux and heart dysfunction. Condi-
tional deletion of Serca2 initiates the progressive loss of SERCA2 protein,
allowing us to examine in fine detail the relationship between titrated loss of
SR Ca2þ flux and heart dysfunction. By four weeks post-knockout, SERCA2
protein levels are below 5% of baseline and isolated 4-week KO cardiomyo-
cytes have greatly diminished contractility and Ca2þ handling. The in vivo phe-
notype at this time, however, is unexpectedly mild, and although all KO mice
succumb to congestive heart failure, they do so from 7-10 weeks after knock-
out. This disconnect between the mild in vivo phenotype and severe ex vivo
phenotype is intriguing and prompts the hypothesis that a systemic signaling
pathway, such as adrenergic signaling, is responsible for sustaining function
in KO animals. We found that in isolated Serca2 KO hearts, ß-adrenergic stim-
ulation elicits a robust inotropic and lusitropic response despite the near-
complete lack of SERCA2 protein. This finding will be discussed as it is at
odds with prevailing views of Ca2þ regulation of heart function.
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The naturally occurring, heterozygous Arg9-to-Cys (R9C) missense mutation
of phospholamban (PLB) triggers dilated cardiomyopathy, heart failure and
premature death in humans. However, the fundamental molecular mechanism
underlying the cardiotoxic role of PLBR9C in regulation of sarcoplasmic retic-
ulum (SR) Ca2þ-ATPase (SERCA) and cardiomyocyte Ca2þ handling is not
clear. The dynamic equilibrium between PLB monomer and pentamer plays
a critical role in SERCA regulation. We compared the effect of R9C and
pentamer-destabilizing transmembrane triple cysteine mutation (SSS) on PLB
pentameric assembly. We co-expressed Cer- or YFP-tagged PLBWT, PLBR9C,
PLBSSS, or PLBR9CþSSS in AAV-293 cells and measured intrapentameric Fluo-
rescence Resonance Energy Transfer (FRET). PLBR9C and PLBR9CþSSS ex-
hibited a significant increase in oligomerization as compared to PLBWT and
PLBSSS, which was further enhanced by application of 100mM H2O2. In addi-
tion, we investigated the stability of PLB pentamer in WT, R9C, SSS, or
R9CþSSS background by molecular dynamic simulation studies. Importantly,
co-expression of CFP-PLBR9C and YFP-PLBR9C in adult rabbit ventricular my-
ocytes exhibited a large and rapid increase in oligomerization over time after
exposure to 100mM H2O2 as compared to PLB
WT. To investigate the effect
